Tinengotinib
Product Specifications
UNSPSC Description
Tinengotinib is the modulator of one or more protein kinases such as Aurora kinase and VEGFR kinase. Tinengotinib has the potential for the research of these kinase abnormalities diseases mediated, especially cancer-related diseases (extracted from patent WO2018108079A1)[1].
Target Antigen
Aurora Kinase; VEGFR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tinengotinib.html
Solubility
DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
ClC1=C(C2=NC3=C(C)NN=C3NC4=C2C=NC(N5CCOCC5)=C4)C=CC=C1
Molecular Weight
394.86
References & Citations
[1]Wu, Yongqian, et al. Multi-kinase inhibitor compound, and crystal form and use thereof. Patent WO2018108079A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145601/Tinengotinib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145601/Tinengotinib-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
2230490-29-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
